ScientifyResearch logo
Grant Alerts

GRANT Guide

Home » Grants » 2023 SITC-Mallinckrodt Pharmaceuticals Adverse Events in Cancer Immunotherapy Clinical Fellowship (worldwide)

2023 SITC-Mallinckrodt Pharmaceuticals Adverse Events in Cancer Immunotherapy Clinical Fellowship (worldwide)

The 2023 SITC-Mallinckrodt Pharmaceuticals Adverse Events in Cancer Immunotherapy Clinical Fellowship from the Society for Immunotherapy of Cancer (SITC) with funding from Mallinckrodt Pharmaceuticals, supports a postdoctoral researcher, resident, research scientist, or comparable position, working on furthering research and translation of adverse events in cancer immunotherapy. Applicants must be a member of the SITC and hold an MD, PhD or MD/PhD degree. Applications are open to candidates worldwide. The fellowship provides funding of 40,000 USD over 1 year plus financial support to attend SITC´s 38th Annual Meeting.

Applications close on March 27, 2023.

Intended for: Clinical residents|Postdoctoral fellows

Discipline: Cancer research|Immuno-oncology|Oncology|Pulmonology

Sign in with your free account to see important eligibility criteria, including research location, citizenship, legal working rights and deadline/s.

Sign-in for link to funder’s page
Create Grant Alerts

…share with your friends

Related Posts

Search all grants
Logo2

more time for research

About
Us

Funding
Blog & Events

Special
Research Funding

Funding by
Career Stage

Funding by
Subject

Funding by
Location

COPYRIGHT © 2023 SCIENTIFYRESEARCH
Logo2

more time for research

COPYRIGHT © 2023 SCIENTIFYRESEARCH

Sign-up for the
scientifyRESEARCH
monthly research
funding newsletter

You can unsubscribe at any time.